Only Small Percentage Of Available Monoclonal Antibody Supply Being Used, Data Indicate

Reuters (12/16, Beasley) reports, “U.S. hospitals have been slow to embrace COVID-19 antibody drugs from Eli Lilly and Co and Regeneron Pharmaceuticals Inc that have been authorized to reduce the risk of hospitalization, U.S. officials said on Wednesday.”...